Abstract |
A patient with longstanding acromegaly complicated by sleep apnea was treated with bromocriptine prior to surgery. In addition to a significant reduction of the plasma growth hormone concentration and measurable decrease in acral overgrowth, a dramatic improvement of the sleep apnea was observed. After three months of therapy, the amount of sleep time occupied by apneic episodes fell from 48 to 12%. The response indicates: (a) that the sequelae sleep apnea in acromegaly can be improved even when ablative therapy of the pituitary is impossible and (b) bromocriptine may prevent perioperative complications caused by clinically significant airway obstruction in patients with acromegaly.
|
Authors | D C Ziemer, D B Dunlap |
Journal | The American journal of the medical sciences
(Am J Med Sci)
Vol. 295
Issue 1
Pg. 49-51
(Jan 1988)
ISSN: 0002-9629 [Print] United States |
PMID | 3337138
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Bromocriptine
- Growth Hormone
|
Topics |
- Acromegaly
(complications, therapy)
- Bromocriptine
(therapeutic use)
- Growth Hormone
(blood)
- Humans
- Male
- Middle Aged
- Preoperative Care
- Sleep Apnea Syndromes
(drug therapy, etiology)
|